Citations

Clear

2960 citation(s) found for "Kim, P".

Adoption and Regional Variation of Prostate-Specific Membrane Antigen Positron Emission Tomography in the United States
Leapman, Michael S., Long, Jessica B., Westvold, Sarah , Rabil, Maximilian , Sprenkle, Preston C. , Kim, Isaac Y., Spilberg, Gabriela , Saperstein, Lawrence, Fallah, Jaleh , Suzman, Daniel L. , Lerro, Catherine, Xu, Jianjin , Rivera, Donna R. , Karnes, R. Jeffrey, Dinan, Michaela, Mitchell, Aaron Philip , Wang, S, Gross, Cary P. , Leapman, Michael , Westvold, Sarah J. , Leapman, Michael S , Dinan, Michaela A , Mitchell, Aaron P , Wang, Shi-Yi , Ma, Xiaomei , Rivera, Donna R. , Kluetz, Paul Gustav , Karnes, R. Jeffrey , Dinan, Michaela A. , Kunst, Natalia , Ma, Xiaomei

Mayo Clinic

JCO Oncology Practice | February 3, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1200/op-25-00617 | PMID 41632928 Get It

PURPOSE Despite evidence of diagnostic accuracy but unclear long-term clinical benefit, national utilization patterns of prostate-specific membrane antigen positron emission tomography (PSMA-PET) are undefined. METHODS We conducted a serial cross-sectional study to evaluate the use of PET imaging among commercial insurance beneficiaries with prostate cancer using administrative claims from deidentified Blue Cross Blue Shield Axis database. Eligible patients included prevalent and incident prostate cancer cases. We calculated the proportions undergoing PET imaging in semiannual periods from January 1, 2016, through December 31, 2024. We examined the association between regional-level contextual sociodemographic and health care characteristics, and regional use of PSMA-PET imaging in 2024. RESULTS A total of 514,750 male beneficiaries age 40-89 years with prostate cancer were identified between 2016 and 2024. The proportion of individuals with prostate cancer undergoing PET imaging increased from 4.5 [95% CI, 4.1 to 4.9] per 1,000 in the first half of 2016 to 77.6 (95% CI, 76.2 to 79.1) per 1,000 in the second half of 2024, P < .001. Increases in PET were driven by uptake of PSMA-PET following approval in 2021, which increased from 0.8 (95% CI, 0.6 to 0.9) per 1,000 in the second half of 2021 to 77.0 (95% CI, 75.5 to 78.5) per 1,000 in the second half of 2024, P < .001. PSMA-PET use in 2024 was higher in regions with greater education (99.3 v 114.6 per 1,000 in lowest [Q1] v highest [Q4] educated) and income (95.4 v 112.3 per 1,000 in Q1 v Q4 income) measures, P < .001. CONCLUSION PSMA-PET was rapidly incorporated into clinical practice among commercial insurance beneficiaries with prostate cancer with higher adoption in geographic regions with higher income and education.
Regulating the regulators via targeting CD38 in the tumor microenvironment
Dutta, Navnita , Halder, Nabanita , Chini, Eduardo N. , Kim, Sungjune , Manna, Alak

Mayo Clinic

Frontiers in Immunology | February 3, 2026 | Volume: 17 | Issue: No issue available | Pages: No page available

10.3389/fimmu.2026.1745988 | PMID 41710886 Get It

The immunosuppressive tumor microenvironment (TME) remains a major barrier to effective cancer immunotherapy. Among the central regulators of immune suppression, CD38, a multifunctional ectoenzyme and surface glycoprotein, has emerged as a pivotal orchestrator. CD38 is abundantly expressed on regulatory T cells (Tregs), regulatory B cells (Bregs), myeloid-derived suppressor cells (MDSCs), tumor-associated macrophages (TAMs), and tumor-associated neutrophils (TANs), where it enhances survival, metabolic fitness, and suppressive activity. Invariant natural killer T (iNKT) cells, which can either promote or suppress antitumor immunity, also express CD38 upon activation, suggesting a role for CD38 in directing their context-dependent fate within the TME. Mechanistically, CD38 regulates immune suppression through NAD + hydrolysis, calcium signaling, and promotion of fatty acid oxidation (FAO) while impairing effector T-cell glycolysis and mitochondrial fitness under chronic hypoxia—conditions that favor exhaustion rather than enhanced cytotoxicity. By depleting extracellular NAD + , CD38 diminishes glycolysis and mitochondrial oxidative phosphorylation in effector T cells, while sustaining regulatory cell persistence through FAO. Its enzymatic products, cyclic ADP-ribose (cADPR) and NAADP, further mobilize calcium fluxes that reinforce suppressive function. CD38 also integrates with hypoxia-driven pathways; in CD38 + Bregs, stabilization of HIF-1α and induction of FAO-related genes such as CPT1A and PPARα/γ promote angiogenesis, immune-evasion, and therapeutic resistance. Therapeutically, targeting CD38 with monoclonal-antibodies, small-molecule inhibitors, or combinations with checkpoint blockade and macrophage-reprogramming agents has shown promise. Such interventions reverse immune suppression, restore effector T cell activity, and enhance tumor responsiveness to immunotherapy. In summary, CD38 functions as both a metabolic regulator and an immunologic checkpoint, coordinating suppressive networks and shaping iNKT cell fate. These multifaceted roles position CD38 as a transformative target for next-generation immunotherapies.
Uncovering the genetic landscape of cholangiocarcinoma and its subtypes via GWAS and integrative analyses
Han, Younghun , Byun, Jinyoung, Cooley, Matthew A. , Shaw, Vikram R., Ahmed, Fowsiyo , Giama, Nasra H., Ali, Hawa M. , Campbell, Nellie A. , Hassan, Mohamed, Andersen, Jesper B., Ankoma-Sey, Victor, Bañales, Jesús M. , Bujanda, L. , Bathe, Oliver F. , Bekaii-Saab, Tanios S., Borad, Mitesh J., Chan, Carlos H.F. , Cleary, S., Folseraas, Trine , Galle, P R, MacInnis, Robert J., Gores, Gregory J., Houlston, Richard S., Ilyas, Sumera, Javle, Milind, Johansen, Julia S., Christensen, Troels Dreier , Kamath, Ashwin S. , Kelley, Robin Kate , Lamarca, Angela, Lammert, F, Lindsey, Stacie , Macias, Rocio I. R., Patel, Tushar, Permuth, Jennifer B., Rossi, Stephen, Sanchez, William, Smoot, Rory L., Swerdlow, Anthony J., Cao, H. Tran, Valle, Juan, Weinmann, A., Wong, Linda L. , Zimmer, Vincent, Zhu, A., Kn, Lazaridis, Juran, Brian D., Jalal, Prasun Kumar, Knox, J., Hutchinson, Amy, Hicks, Belynda, Chanock, Stephen J., Hassan, Manal M. , Amos, Christopher I., McGlynn, Katherine A., Roberts, Lewis R., Roberts, Lewis R. , Sánchez, William , Han, Younghun , Byun, Jinyoung , Byun, Jinyoung , VanLith, Caitlin J. , Roberts, Lewis R , Banales, Jesus M , Jalal, Prasun K , Chan, Carlos H F , Sanchez, William , Shaw, Vikram R. , Hatia, Rikita , Andersen, Jesper B , Ankoma‐Sey, Victor, Bekaii‐Saab, Tanios , Borad, Mitesh J. , Björkström, Niklas K. , Cleary, Sean P. , Cornillet, Martin , Galle, Peter R., Genkinger, Jeanine M. , MacInnis, Robert J. , Gores, Gregory J. , Goyal, Lipika , Houlston, Richard S. , Ilyas, Sumera I. , Javle, Milind , Johansen, Julia S., Khan, Shahid Ali , Kim, Richard D. , Kwee, Sandi Alexander , Lamarca, Angela , LaRusso, Nicholas F. , Malhi, Harmeet , Permuth, Jennifer B. , Reeves, Helen L. , Smoot, Rory L. , Swerdlow, Anthony J , Weinmann‐Menke, Julia , Zhang, Xuehong , Zimmer, Vincent , Zhu, Andrew X. , Jalal, Prasun K. , Hutchinson, Amy , Hicks, Belynda , Koshiol, Jill , Chanock, Stephen Jacob , Amos, Christopher I. , McGlynn, Katherine A.

Mayo Clinic

Hepatology | February 2, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1097/hep.0000000000001699 | PMID 41627892 Get It

Background and Aims: Cholangiocarcinoma (CCA) is a rare but aggressive malignancy with poorly understood genetic susceptibility. To date, genome-wide association studies (GWAS) investigating germline variants associated with CCA risk remain limited. We aimed to identify genetic risk loci for CCA and its clinical subtypes through comprehensive GWAS and post-GWAS analyses. Approach and Results: We conducted a GWAS of 2366 CCA cases and 11,750 controls of European ancestry. Genome-wide significant loci ( p <5×10 −8 ) were identified and further examined through fine-mapping, functional annotation, and HLA imputation. Subgroup analyses were conducted by CCA subtypes and primary sclerosing cholangitis (PSC) status. Cross-trait linkage disequilibrium score regression and Mendelian randomization were employed to investigate the shared genetic architecture and potential causal relationships with a diverse range of traits. We identified 1 new genome-wide significant variant, rs535777 (OR=1.44), near HLA-DRB1/DQA1 associated with CCA, and 2 variants associated with extrahepatic CCA: rs116224263 (OR=0.17) in LINC02506 at 4p15.1 and rs6914950 (OR=1.63) near HLA-DRB1/DQB1 . Stratified analyses revealed rs2395184 (OR=3.51) near HLA-DRA/DRB5 associated with PSC-related CCA, and rs142674434 (OR=2.98) in THSD7A at 7p21.3 associated with non-PSC-related CCA. HLA imputation uncovered new amino acid residues associated with disease risk. Cross-trait analyses identified shared genetic signals between CCA and anthropometric, lipidemic, lifestyle, and medical traits. Mendelian randomization supported putative causal associations for 12 traits with CCA or its subtypes. Conclusions: Our large-scale GWAS highlights new genetic variants and HLA-linked mechanisms underlying CCA susceptibility. Integrating multi-step post-GWAS approaches enhances understanding of CCA pathogenesis and may facilitate the development of risk biomarkers for early detection and precision prevention strategies.
Leukocyte Telomere Length Variants Are Independently Associated with Survival of Patients with Colorectal Cancer
Sarkar, Gobinda , Chen, Jun, Sood, Shubham , Fischer, K., Kossick, Kim, Schupack, Daniel , Graham, Rondell, Druliner, Brooke, Heydari, Zahra , Helgeson, Lauren, Garcia, Estela Cruz, Cawthon, Richard , Boardman, Lisa, Graham, Rondell P. , Garcia, Edwin , Fischer, Karen, Graham, Rondell P , Cruz Garcia, Estela Mariel , Chen, Jun, Druliner, Brooke R. , Boardman, Lisa

Mayo Clinic

Cancers | February 2, 2026 | Volume: 18 | Issue: 3 | Pages: 490

10.3390/cancers18030490 | PMID 41681962 Get It

Background and aims: Aberrations in telomere length can have important implications in cancer. Using a cohort of 1007 patients, we investigated whether leukocyte telomere length (LTL) in patients with colorectal cancer (CRC) is associated with survival. We also investigated whether some telomere maintenance genes are associated with survival in these patients. Methods: The Biobank for Gastrointestinal Health Research (BGHR), an ongoing project involving collection of biospecimens at the Mayo Clinic, was utilized to obtain data from patients diagnosed with stage II or III CRC. Blood samples were collected prior to chemotherapy/radiation and DNA was extracted for measuring median LTL. The main outcome measures were overall survival (OS) and disease-free survival (DFS) by disease stage. Results: A significant inverse relationship was observed with patient age and LTL (spearman correlation coefficient (r) = −0.48, 95%; p = 1.13 × 10−58). Females had significantly longer LTL than males (p = 3.97 × 10−5). The rs1317082 SNP in the TERC gene was significantly associated with both OS and DFS in combined stage II and stage III patients (p = 0.017 and p = 0.023, respectively). A statistically significant association of the OBFC1 SNP (rs9419958) was observed for OS for the combined stage II and stage III patients (p = 0.016). Importantly, LTL was significantly associated with both OS and DFS (p = 0.008 and 0.044 respectively) in combined stage II and stage III patients. Conclusions: Our results show that LTL is predictive of OS and DFS for stage II and III CRC patients, particularly over a longer follow-up, extending beyond five years after a diagnosis of CRC, and certain SNPs in genes involved in telomere maintenance are significantly associated with patient outcomes, independent of telomere length.
Mapping Microvascular Flow via Radon Transform Ultrasound: Technical Advances and Pilot Application
Yin, Jingyi , Huang, Lijie, Zhang, Jingke , DeRuiter, Ryan M., Zhu, Xiang-yang, Krier, James D., Kim, Y, Zhao, Y., Ji, Kaipeng , Lerman, L. O., Chen, S., Huang, Chengwu , Zhao, Yanzhe , Huang, Chengwu , Zhang, Jingke , Huang, Lijie, Lok, U‐Wai , DeRuiter, Ryan M. , Lucien, Fabrice , Lerman, Lilach O.

Mayo Clinic

BME Frontiers | January 30, 2026 | Volume: 7 | Issue: No issue available | Pages: No page available

10.34133/bmef.0234 | PMID 42317226 Get It

Objective: This study aims to develop a contrast-free, high-sensitivity ultrasound method, denoted as Radon transform-based flow measurement (R-Flow), for in vivo mapping of microvascular flow vectors and for establishing R-Flow-derived vector-field metrics to noninvasively quantify microcirculatory patterns in liver cirrhosis. Impact Statement: R-Flow enables robust, contrast-free imaging of microvascular dynamics and demonstrates translational feasibility in the human liver. Its direction-aware indices offer pilot in vivo quantification of flow redistribution and remodeling, providing unique insights into hepatic flow dynamics. Introduction: Microvascular dysfunction is a hallmark of many diseases, yet noninvasive visualization and quantitative assessment of abnormal microcirculation remain limited. Methods: R-Flow leverages Radon transform to decode red blood cell dynamics from the spatiotemporal domain of ultrasound flow signals, reconstructing velocity vectors at microvascular scale. From these vector maps, unique direction-aware indices are further derived to characterize flow distribution and heterogeneity. Results: Validated across simulations, phantoms, and in vivo studies, R-Flow provides robust velocity estimation across a wide range (1 to 60 mm/s). Notably, it enables high-sensitivity microvascular flow vector mapping of human liver, showing strong agreement with references ( r > 0.9). In a rat model, these direction-aware indices revealed a shift from healthy multipath perfusion in control livers to directionally biased vascular pattern in cirrhotic livers, demonstrating significant correlation with pathological indicators. Conclusion: R-Flow enables noninvasive, contrast-free mapping of microvascular blood flow velocity and offers a promising approach for high-resolution assessment of microvascular flow characteristics.
Abstract DP029: Incidence, risk factors, aneurysm growth, and outcomes of cervical artery dissection patients with dissecting aneurysm: STOP-CAD subanalysis
Khan, Muhib, Keser, Zafer, Nguyen, Thanh N., Lee, Elizabeth M., Ho, Melanie, Shu, Liqi , Klein, Piers, Mallick, Dania, Griffin, Kim, Mandel, Daniel M, Leker, Ronen, Metanis, Issa, Krishnaiah, Balaji , Omran, Setareh Salehi , Bakradze, Ekaterina, Henninger, Nils, Engelter, Stefan T, Katheryna, Antonenko, Marto, Joao Pedro, Rothstein, Aaron, Khazaal, Ossama , Nolte, Christian H., Crandall, Ross , Lester, Evan, MacGrory, Brian, Ghannam, Malik, AlMajali, Mohammad, Zubair, Adeel , Elnazeir, Marwa , Kasab, Sami Al, Asad, Syed Daniyal , Balabhadra, Anvesh , Cruz, Diana García, Romoli, Michele, Velez, Faddi Saleh, Sen, Shayak, Zedde, Marialuisa, Samaniego, Edgar, Stretz, Christoph, Kam, Wayneho , AbdalKader, Mohamad, Yaghi, Shadi, Henninger, Nils , Henninger, Nils , Khan, Muhib , Keser, Zafer , Klein, Piers , Leker, Ronen R , Metanis, Issa , Shahripour, Reza Bavarsad , Bakradze, Ekaterina , Engelter, Stefan T. , Heldner, Mirjam R. , Siegler, James E. , Marto, João Pedro , Rothstein, Aaron , Nolte, Christian H. , Nehme, Ahmad , Ghannam, Malik , Kasab, Sami Al , Fonseca, Ana Catarina , Cruz, Diana, Romoli, Michele , Velez, Faddi G. Saleh , Simpkins, Alexis N. , Zedde, Marialuisa , Stretz, Christoph , Abdalkader, Mohamad , Yaghi, Shadi

Mayo Clinic

Stroke | January 29, 2026 | Volume: 57 | Issue: Suppl_1 | Pages: No page available

10.1161/str.57.suppl_1.dp029 Get It

Background: Cervical artery dissection (CeAD) accounts for nearly 25% of all ischemic strokes in young adults. CeAD can lead to the development of dissecting aneurysms (DA). However, the incidence, risk factors and outcomes of CeAD patients with DA is not well established. This study aims to identify risk factors for developing DA, subsequent growth, and impact on patient outcomes. Methods: This is a secondary analysis of the Antithrombotics for Stroke Prevention in Cervical Artery Dissection (STOP-CAD), a multicenter cross-sectional international retrospective study. CeAD patients were stratified for the presence of DA. We used multivariable regression to identify factors associated with DA. Patients with DA were further analyzed for DA growth. The primary outcome was ischemic stroke after CeAD+DA diagnosis. Secondary outcomes included ischemic stroke after CeAD+DA with DA growth. Multivariable logistic regression analysis was used to assess the association between DA and risk factors. We also performed univariate Cox regression and generated Kaplan-Meier survival curves comparing study outcomes based on presence of DA and subsequent growth. Results: Of the 4023 patients included in the STOP-CAD study, 4008 were included in this analysis and 767 (19%) patients had DA (546 with DA on initial presentation). Patients with DA had a mean age of 46 [IQR 37-55] years and 50% (383) were women. In combined adjusted analyses, DA patients were more often non-Hispanic (aOR 0.63, 95% CI 0.41-0.94, p<0.02), more commonly had a history of migraine (aOR 1.27, 95% CI 1.01-1.59, p=0.037), connective tissue disorder (aOR 2.02, 95% CI 1.22-3.36, p=0.007), minor neck trauma (aOR 1.70, 95% CI 1.29-2.26, p<0.001) and were more likely to present with ischemic stroke (aOR 1.73, 95% CI 1.05-2.87, p=0.031). DA growth was noted in 55 out of 546 (10%) patients with DA on presentation. There was no significant difference in the risk of ischemic stroke by day 180 in patients with DA (hazard ratio [HR] 0.92 [95% CI, 0.65-1.30]; P =0.63) or DA growth (HR 2.40, [95% CI, 0.79-7.24]; P =0.12). Conclusion: In this subanalysis of STOP-CAD, nearly one in five patients with CeAD developed a DA. Factors associated with a higher likelihood of DA included non-Hispanic ethnicity, history of migraine, connective tissue disorder, minor neck trauma, and ischemic stroke at presentation. DA diagnosis and DA growth did not impact the risk of subsequent ischemic stroke at 6 months.
Abstract A048: De Novo Pseudoaneurysm Formation After Cervical Artery Dissection: Incidence, Risk Factors, and Outcomes
Keser, Zafer, Khan, Muhib, Nguyen, Thanh N., Lee, Elizabeth M., Shu, Liqi , Ho, Melanie, Klein, Piers, Mallick, Dania, Griffin, Kim, Mandel, Daniel M, Leker, Ronen, Metanis, Issa, Krishnaiah, Balaji , Omran, Setareh Salehi , Bakradze, Ekaterina, Henninger, Nils, Engelter, Stefan T, Marto, Joao Pedro, Rothstein, Aaron, Khazaal, Ossama , Nolte, Christian H., Crandall, Ross , Lester, Evan, AlMajali, Mohammad, Ghannam, Malik, Zubair, Adeel , Elnazeir, Marwa , Kasab, Sami Al, Asad, Syed Daniyal , Balabhadra, Anvesh , Romoli, Michele, Cruz, Diana, Velez, Faddi Saleh, Sen, Shayak, Marialuisa, Zedde, Samaniego, Edgar A., Stretz, Christoph, Kam, Wayneho , AbdalKader, Mohamad, Yaghi, Shadi, Henninger, Nils , Henninger, Nils , Keser, Zafer , Khan, Muhib , Ho, Melanie, Klein, Piers , Leker, Ronen R , Metanis, Issa , Shahripour, Reza Bavarsad , Bakradze, Ekaterina , Engelter, Stefan T. , Heldner, Mirjam R. , Antonenko, Kateryna , Siegler, James E. , Marto, João Pedro , Rothstein, Aaron , Nolte, Christian H. , Nehme, Ahmad , Grory, Brian Mac , Ghannam, Malik , Kasab, Sami Al , Fonseca, Ana Catarina , Romoli, Michele , Cruz, Diana , Velez, Faddi G. Saleh , Simpkins, Alexis N. , Samaniego, Edgar A , Stretz, Christoph , Abdalkader, Mohamad , Yaghi, Shadi

Mayo Clinic

Stroke | January 29, 2026 | Volume: 57 | Issue: Suppl_1 | Pages: No page available

10.1161/str.57.suppl_1.a048 Get It

Background: The clinical characteristics and complications associated with de novo pseudoaneurysm formation beyond the acute phase of cervical artery dissection remain poorly defined. In this study, we examined the incidence, risk factors, and related ischemic and hemorrhagic events of post-acute de novo pseudoaneurysm formation. Methods: We analyzed data from the STOP-CAD study (Antithrombotic Treatment for Stroke Prevention in Cervical Artery Dissection). A de novo pseudoaneurysm was defined as a new (not present on initial imaging) focal enlargement in the diameter of the artery, greater than the native lumen. The incidence of de novo pseudoaneurysm was assessed at 90 days, 180 days, and beyond 180 days of follow-up. Univariate and multivariate regression analyses were conducted to identify risk factors for post-acute de novo pseudoaneurysm formation. Kaplan-Meier survival estimates were used to compare ischemic and hemorrhagic events between patients with and without de novo pseudoaneurysms. Results: Among 4008 patients, 546 were excluded as they had dissecting pseudoaneursyms on initial presentation. Therefore, 3,462 patients were included in this analysis of whom 220 patients (6.35%) developed a de novo pseudoaneurysm over a maximum follow-up of 4.4 years. Of these, 127 (57.72%) were detected within the first 90 days, and 172 (78.18%) within the first 180 days. In multivariate regression analyses, in addition to hypertension, active smoking and Hispanic ethnicity, fibromuscular dysplasia (FMD) was an independent risk factor for post-acute de novo pseudoaneurysm formation (adjusted OR: 2.160; 95% CI: 1.408–3.315; p < 0.001). Notably, the presence of a de novo pseudoaneurysm was not associated with a significant increase in ischemic (hazard ratio [HR] 1.43 [95% CI, 0.89–2.30]; P=0.14) or hemorrhagic events (hazard ratio [HR] 1.42 [95% CI, 0.43–4.69]; P=0.57). Conclusion: De novo pseudoaneurysm formation following a diagnosis of a cervical artery dissection is not uncommon and most frequently occurs within the first 180 days. FMD was independently associated with this complication. The development of a de novo pseudoaneurysm did not significantly increase the risk of subsequent ischemic or hemorrhagic events.
Abstract A029: Diagnostic Yield of Cardiac CT to Detect Cardiac Thrombi in Acute Ischemic Stroke: an Individual Patient Data Meta-Analysis.
Nio, Shan Sui , Green, Daniel B. , Berry, Alexander , Rinkel, Leon A, Planken, R. Nils, Randen, Adriënne van , Hilt, Mirre , Ruhe, Deborah, Bouma, B., Boekholdt, S, Chew, Beng Lim Alvin , Fridgant, Joshua, ROMO, LUIS MENA, Guo, Shuyu, Winders, Joel, Senadeera, Sajith C. , Lim, Anthony , Fink, John , Leung, Melissa , Parsons, Mark, Spratt, N., Garcia-Esperon, Carlos, Wu, Teddy, Coutinho, Jonathan M. , Green, Daniel, Rinkel, Leon A. , Beemsterboer, Chiel F.P. , Hasnain, Md Golam , Planken, R. Nils , Boekholdt, S. Matthijs , Romo, Luis Mena, Kim, Dong Hyun , Alamri, Yassar , Lim, Anthony T , Leung, Melissa , Cordato, Dennis , Spratt, Neil J , Garcia-Esperon, Carlos , Wu, Teddy Y

Mayo Clinic

Stroke | January 29, 2026 | Volume: 57 | Issue: Suppl_1 | Pages: No page available

10.1161/str.57.suppl_1.a029 Get It

Background: Cardiac CT acquired during the acute stroke imaging protocol is an emerging diagnostic modality to detect cardiac thrombi. We aimed to determine its diagnostic yield in a large, international, multicenter study. Methods: We performed an individual patient data meta-analysis by pooling prospective and retrospective observational data of patients with acute ischemic stroke (AIS) who underwent cardiac CT (ECG-gated or non-ECG-gated) as part of the acute imaging protocol between May 2018 and June 2024. We excluded patients with a TIA or stroke mimic. The primary outcome was the proportion of patients with a cardiac thrombus detected on cardiac CT. Secondary outcomes were additional scan time and radiation dose, comparison of yield with echocardiography, and 90-day mortality and recurrent ischemic stroke rates. Results: We included 3940 patients from 4 hospitals (median age 74 [IQR 63-82], 58.0% male, median NIHSS 6 [IQR 3-12], median time onset to hospital arrival 100 minutes [IQR 62-185]). Atrial fibrillation at baseline was present in 23.1% patients, and 29.6% had a large vessel occlusion. Cardiac CT was non-diagnostic in 17 (0.4%) patients. In total, cardiac CT detected 254 cardiac thrombi in 243/3923 (6.2%) patients. Thrombi were located in the left atrial appendage (n=193), left atrium (n=19), and left ventricle (n=42). Of 95/243 (39.1%) patients with a cardiac thrombus that underwent echocardiography (median interval cardiac CT-echocardiography: 2 days), transthoracic echocardiography detected a thrombus in 18/92 (19.6%) patients and transesophageal echocardiography in 2/5 (40.0%) patients. The diagnostic yield in patients that underwent both modalities was higher for cardiac CT (OR 7.5 [CI 4.0-15.3], p<0.001). Median additional scan time was 6 minutes (IQR 5-7) for ECG-gated and 17 seconds (IQR 15-63) for non-ECG-gated cardiac CT. Median additional radiation dose was 5.4mSv (IQR 3.0-7.6). Patients with a cardiac thrombus on cardiac CT had higher 90-day mortality than those without a thrombus (33.3% vs 14.6%, p<0.001). We found no difference in 90-day recurrent stroke rate (5.4% vs 4.4%, p=0.50). Conclusion: Routine cardiac CT performed during the acute stroke imaging protocol detects a cardiac thrombus in 1 out of 16 patients with AIS, with a 7-times higher yield than routine echocardiography. Mortality rate was doubled in patients with a cardiac thrombus, but 90-day stroke recurrence risk did not differ.
Abstract DP126: ECG-gated versus non-ECG-gated cardiac CT protocols for cardiac thrombus detection in acute ischemic stroke.
ROMO, LUIS MENA, Nio, Shan Sui , Berry, Alexander , Spratt, N., Green, Daniel, Hasnain, Md, Chew, Beng Lim Alvin , Fridgant, Joshua, Rinkel, Leon A, Beemsterboer, Chiel, Planken, R. Nils, Randen, Adriënne van , Hilt, Mirre, Ruhe, Deborah, Bouma, B., Boekholdt, S, Kim, Dong Hyun, Guo, Shuyu, Winders, Joel, Senadeera, Sajith C. , Lim, Anthony , Fink, John , Leung, Melissa, Parsons, Mark, Wu, Teddy, Coutinho, Jonathan, Garcia-Esperon, Carlos, Romo, Luis Mena, Spratt, Neil J , Hasnain, Md Golam , Rinkel, Leon A. , Beemsterboer, Chiel F.P. , Planken, R. Nils , Hilt, Mirre , Boekholdt, S. Matthijs , Alamri, Yassar , Lim, Anthony T , Cordato, Dennis , Parsons, Mark W , Wu, Teddy Y , Garcia-Esperon, Carlos

Mayo Clinic

Stroke | January 29, 2026 | Volume: 57 | Issue: Suppl_1 | Pages: No page available

10.1161/str.57.suppl_1.dp126 Get It

Background: The rate of intracardiac thrombus detection in the hyperacute phase of stroke varies from 5% to 12% between studies. Our aim was to compare the thrombus detection rate between ECG-gated and non-ECG-gated cardiac CT protocols in acute stroke patients, using data from a large, international, multicentre registry. Methods: We conducted an individual patient data meta-analysis by pooling prospective and retrospective observational data from stroke patients assessed at four comprehensive stroke centres who underwent either ECG-gated or non-ECG-gated cardiac CT (extended CT angiography or two-phase non-ECG-gated cardiac CT) as part of the acute stroke imaging protocol between May 2018 and June 2024. The primary outcome was the proportion of patients with a cardiac thrombus in gated vs non gated techniques. Results: Of 3,940 patients, 1,474 (37.4%) underwent ECG-gated and 2,466 (62.6%) non-ECG-gated cardiac CT. Patients in the ECG-gated group were younger (median age 72 [IQR 62–81] vs. 74 [IQR 64–82] years, p = 0.000) and had a lower NIHSS at baseline (median 5 [IQR 2–12] vs. 6 [IQR 3–13], p < 0.00). There was a higher rate of thrombus detection with ECG-gated CT compared to non-gated CT (7.5% vs. 5.5%, p = 0.011. The association remained significant after adjusting for age, sex, baseline NIHSS score, and baseline atrial fibrillation (adjusted OR 1.87, 95% CI 1.42–2.47, p = 0.000). ECG-gated CT was associated with lower radiation dose (3.6 vs. 6.3 mSv, p = 0.000) but longer acquisition time (5.8 vs. 0.28 min, p = 0.000). Conclusion: ECG-gated cardiac CT has a higher detection rate for intracardiac thrombus detection compared to non-ECG-gated CT in patients with acute ischemic stroke.
Dissecting Aneurysm in Cervical Artery Dissection: Insights From the STOP-CAD Study
Khan, Muhib, Keser, Z, Shu, Liqi , Lee, Elizabeth M., Ho, Melanie, Klein, Piers, Mallick, Dania, Griffin, Kim, Mandel, Daniel M, Leker, Ronen R., Metanis, Issa, Krishnaiah, Balaji , Omran, Setareh Salehi , Bakradze, Ekaterina, Henninger, Nils, Engelter, Stefan T, Antonenko, Kateryna, Marto, Joao Pedro, Rothstein, Aaron, Khazaal, Ossama , Nolte, Christian H., Crandall, Ross Curtiss, Lester, Evan, Nehme, Ahmad , Ghannam, Malik, AlMajali, Mohammad, Elnazeir, Marwa , Kasab, Sami Al, Asad, Syed Daniyal , Balabhadra, Anvesh , Fonseca, Ana Catarina , Cruz, Diana , Romoli, Michele, Sen, Shayak, Zedde, Marialuisa, Samaniego, Edgar A., Zubair, Adeel , Stretz, Christoph, Kam, Wayneho , AbdalKader, Mohamad, Yaghi, Shadi, Nguyen, Thanh N., Keser, Zafer , Klein, Piers , Henninger, Nils , Mandel, Daniel , Lee, Elizabeth , Nolte, Christian H. , Khan, Muhib , Keser, Zafer , Lee, Elizabeth , Klein, Piers , Griffin, Kim J. , Mandel, Daniel M , Leker, Ronen R , Metanis, Issa , Salehi Omran, Setareh , Bakradze, Ekaterina , Henninger, Nils , Engelter, Stefan T , Heldner, Mirjam R , Antonenko, Kateryna , Siegler, James E , Marto, João Pedro , Rothstein, Aaron , Khazaal, Ossama , Nolte, Christian H , Crandall, Ross , Nehme, Ahmad , Mac Grory, Brian , Ghannam, Malik , Almajali, Mohammad , Elnazeir, Marwa , Al Kasab, Sami , Asad, Syed Daniyal , Balabhadra, Anvesh , Fonseca, Ana Catarina , Cruz, Diana , Romoli, Michele , Saleh Velez, Faddi , Simpkins, Alexis N , Zedde, Marialuisa , Samaniego, Edgar A , Zubair, Adeel , Stretz, Christoph , Kam, Wayneho , Abdalkader, Mohamad , Yaghi, Shadi , Nguyen, Thanh N , Khan, Muhib , Ho, Melanie, Metanis, Issa , Shahripour, Reza Bavarsad , Bakradze, Ekaterina , Engelter, Stefan T. , Heldner, Mirjam R. , Siegler, James E. , Marto, João Pedro , Rothstein, Aaron , Crandall, Ross , Grory, Brian Mac , Ghannam, Malik , Kasab, Sami Al , Velez, Faddi G. Saleh , Simpkins, Alexis N. , Zedde, Marialuisa , Stretz, Christoph , Abdalkader, Mohamad , Yaghi, Shadi

Mayo Clinic

Stroke | January 29, 2026 | Volume: 57 | Issue: 4 | Pages: 865-875

10.1161/strokeaha.125.054847 | PMID 41608793 Get It

BACKGROUND: Cervical artery dissection (CeAD) may result in dissecting aneurysm (DA) formation. We aimed to characterize risk factors and clinical outcomes associated with DA in a large, international CeAD cohort. METHODS: We performed a secondary analysis of STOP-CAD (Antithrombotic Treatment for Stroke Prevention in Cervical Artery Dissection), an international, multicenter, retrospective cohort. Patients with spontaneous CeAD were assessed for DA at baseline and de novo DA formation. Significant covariates in univariable analysis were included in multivariable regression models aiming to identify factors associated with DA formation. Logistic regression and Cox proportional hazards models evaluated the association of DA with ischemic and hemorrhagic outcomes. RESULTS: Among 4008 patients with CeAD, 546 (13.6%) had a DA at baseline, and 221/2938 (7.5%) patients developed a de novo DA during follow-up, of which 172/221 (78.2%) were detected in the first 180 days. Patients with DA had a mean age of 47 years, and 383 (49.9%) were women. Baseline or de novo DA was associated with a history of connective tissue disorder (adjusted odds ratio [aOR], 2.02 [95% CI, 1.22–3.36]), fibromuscular dysplasia (aOR, 1.69 [95% CI, 1.28–2.25]), and multiple vessel dissection (aOR, 1.53 [95% CI, 1.19–1.98]). Lower odds of DA were seen in Hispanic ethnicity (aOR, 0.64 [95% CI, 0.43–0.97]) and ischemic stroke presentation (aOR, 0.41 [95% CI, 0.34–0.49]). Fibromuscular dysplasia was associated with de novo DA formation (aOR, 2.30 [95% CI, 1.52–3.49]). DA was not associated with ischemic stroke (hazard ratio, 0.71 [95% CI, 0.44–1.16]; P =0.173) or intracranial hemorrhage (HR, 1.09 [95% CI, 0.42–2.84]; P =0.86) by day 180. CONCLUSIONS: DAs are relatively common manifestations of CeAD, typically occurring within 6 months of CeAD diagnosis. DA was not associated with an increased risk of subsequent ischemic stroke or intracranial hemorrhage.